Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 1.00 |
| ▸ | MGLL | Q99685 | 1/20 | 0.75 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | ARG2 | P78540 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | TNKS | O95271 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.46 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Styrylboronic Acid SCHEMBL144460 | 1.00 | CA1 (1.00) | CA1MGLLMAOBCA2ARG2 | |
| Styrylboronic Acid SCHEMBL144461 | 1.00 | CA1 (1.00) | CA1MGLLMAOBCA2ARG2 | |
| Styrylboronic Acid SCHEMBL4390084 | 0.97 | CA1 (0.95) | CA1MGLLMAOBCA2ARG2 | |
| Styrylboronic Acid SCHEMBL28579652 | 0.87 | CA1 (0.76) | CA1MGLLMAOBCA2ARG2 | |
| SCHEMBL2910475 | 0.86 | CA1 (1.00) | CA1MGLLMAOBCA2ARG2 | |
| SCHEMBL12260418 | 0.86 | CA1 (1.00) | CA1MGLLMAOBCA2ARG2 | |
| SCHEMBL8011423 | 0.84 | CA1 (0.73) | CA1MGLLMAOBALDH1A1LMNA | |
| (Z)-1,2-Diphenylethene SCHEMBL29134000 | 0.76 | MAOB (0.69) | CA1MAOBALDH1A1LMNAHDAC3 | |
| SCHEMBL23044739 | 0.75 | CA1 (0.61) | CA1MGLLMAOBCA2MAPT | |
| SCHEMBL13204210 | 0.75 | CA1 (0.61) | CA1MGLLCA2TRPA1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441669-B2 | PCNHCP metal complexes and uses thereof | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2025-10-14 | — | — | US | disclosed |
| CN-117756303-A | Preparation method of composite scale and corrosion inhibitor for water treatment | 佛山市栢豪环保科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20230322647-A1 | PCNHCP METAL COMPLEXES AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2023-10-12 | — | — | US | disclosed |
| WO-2022043993-A1 | PCNHCP METAL COMPLEXES AND USES THEREOF | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2022-03-03 | — | — | WO | disclosed |
| US-20180327355-A1 | ISOINDOLINE DERIVATIVES | VIIV HEALTHCARE UK LIMITED (GB) | 2018-11-15 | — | — | US | disclosed |
| US-20160126478-A1 | EMISSIVE COMPOUNDS FOR LIGHT EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| US-20090004185-A1 | AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF BETA-CATENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS | WYETH (US) | 2009-01-01 | — | — | US | disclosed |
| US-20080306127-A9 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | INFINITY PHARMACEUTICALS, INC. (US) | 2008-12-11 | — | — | US | disclosed |
| US-20070161690-A1 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | INFINITY PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | US | disclosed |
| US-20060020004-A1 | Isoxazolidine compounds for treatment of bacterial infections | INFINITY PHARMACEUTICALS, INC. (US) | 2006-01-26 | — | — | US | disclosed |
| WO-2006009907-A2 | ISOXAZOLIDINE COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | INFINITY PHARMACEUTICALS, INC. (US) | 2006-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020004-A1 | Isoxazolidine compounds for treatment of bacterial infections | QDPR, NQO2, SQLE | CA1 4344/4885MGLL 1990/4885MAOB 160/4885 |
| US-20230322647-A1 | PCNHCP METAL COMPLEXES AND USES THEREOF | PIN4, HIRIP3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | CA1 728/4885MGLL 4059/4885MAOB 3332/4885 |
| US-20090004185-A1 | AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF BETA-CATENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS | TCF4, CTNNB1, TCF7 | CA1 4688/4885MGLL 4367/4885MAOB 3491/4885 |
| US-20080306127-A9 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | BCL3, BCL2, BCLAF1 | CA1 2898/4885MGLL 4034/4885MAOB 3618/4885 |
| US-20180327355-A1 | ISOINDOLINE DERIVATIVES | IRF3, EIF2AK2, MAVS | CA1 4024/4885MGLL 3447/4885MAOB 857/4885 |
| US-20070161690-A1 | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | BCL3, BCL2, BCLAF1 | CA1 2898/4885MGLL 4034/4885MAOB 3618/4885 |
| US-12441669-B2 | PCNHCP metal complexes and uses thereof | PIN4, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HIRIP3 | CA1 755/4885MGLL 3886/4885MAOB 2826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.